Effect of the peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 647-654

  Binder, Waltraud ^a   Walker, Judith S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

agonist; antagonist; Adjuvant arthritis; Analgesia; Asimadoline; Inflammation; Motor activity; MR2266; Naloxone methiodide; Peripheral effects

Indexed keywords

17 METHYLNALOXONE; 5,9 DIETHYL 2 (3 FURYLMETHYL) 2' HYDROXY 6,7 BENZOMORPHAN; ASIMADOLINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACETAMIDES; ADMINISTRATION, ORAL; ANALGESICS, OPIOID; ANIMALS; ARTHRITIS, EXPERIMENTAL; BENZOMORPHANS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PYRROLIDINES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, INBRED LEW; RECEPTORS, OPIOID, KAPPA; TIME FACTORS;

EID: 0031861374     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701874     Document Type: Article

References (26)

1. ACKERMAN, N.R., ROOKS, W.H., SHOTT, L., GENANT, H., MALONEY, P. & WEST, E. (1979). Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arth. Rheum., 22, 1365-1373.
2. BARBER, A., BARTOSYK, G.D., BENDER, H.M., GOTTSCHLICH, R., GREINER, H.E. HARTING, J. MAULER, F., MINCK, K.O., MURRAY, R.D., SIMON, M. & SEYFRIED, C.A. (1994). A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br. J. Pharmacol., 113, 1317-1327.
3. BARBER, A. & GOTTSCHLICH, R. (1992). Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med. Res. Rev., 12, 525-562.
4. BARBER, A. & GOTTSCHLICH, R. (1997). Novel developments with selective, non-peptide Kappa-opioid receptor agonists. Exp. Opin. Invest. Drugs, 6, 1351-1368.
5. BIDLACK, J.M., SARIPALLI, L.D. & LAWRENCE, D.M. (1992). Kappa-opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol., 227, 257-265.
6. BOERS, M. & TUGWELL, P. (1993). The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J. Rheumatol., 20, 568-574.
7. CARR, D.J.J. (1994). The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med., 198, 710-720.
8. CARR, D.J.J., BOST, K.L. & BLALOCK, J.E. (1988). The production of antibodies which recognize opiate receptors on murine leukocytes. Life Sci., 42, 2615-2624.
9. GOTTSCHLICH, R., BARBER, A., BARTOSZYK, G.D. & SEYFRIED, C.A. (1995). The peripherally acting κ-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity. Drugs Exp. Clin. Res., 21, 171-174.
10. GOTTSCHLICH, R., KRUG, M., BARBER, A. & DEVANT, R.M. (1994). Κ-Opioid activity of the four stereoisomers of the peripherally selective κ-agonists, EMD 60 400 and EMD 61 753. Chirality, 6, 685-689.
11. HORWELL, D.C. (1988). Kappa opioid analgesics. Drugs Future, 13, 1061-1070.
12. PINCUS, T. (1994). Rheumatoid arthritis: A medical emergency? Scand. J. Rheumatol., 23, (suppl 100), 21-30.
13. RUSSELL, N.S.W., SCHAIBLE, H.-G. & SCHMIDT, R.F. (1987). Opiates inhibit the discharges of the afferent units from inflamed knee joint of the cat. Neurosci. Lett., 76, 107-112.
14. SARNE, Y., FIELDS, A., KEREN, O. & GAFNI, M. (1996). Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem. Res., 21, 1353-1361.
15. SCHAIBLE, H. & SCHMIDT, R.F. (1985). Effects of an experimental arthritis on the sensory properties of line articular afferent units. J. Neurophysiol., 54, 1109-1122.
16. STEIN, C. (1991). Peripheral analgesic actions of opioids. J. Pain Sympt. Manag., 6, 119-124.
17. STEIN, C. (1995). The control of pain in peripheral tissue by opioids. N. Engl. J. Med., 332, 1685-1690.
18. STEIN, C., HASSAN, A.H.S., LEHRBERGER, K., GIEFING, A. & YASSOURIDIS, A. (1993). Local analgesic effect on endogenous opioid peptides. Lancet, 342, 321-324.
19. TAUB, D.D., EINSTEIN, T.K., GELLER, E.B. & ADLER, M.W. (1991). Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc. Natl. Acad. Sci. U.S.A., 88, 360-364.
20. THOMAS, P.T., BHARGAVA, H.N. & HOUSE, R.V. (1995). Immunomodulatory effects of in vitro exposure to morphine and its metabolites. Pharmacology, 50, 51-62.
21. WALKER, J.S., CHANDLER, A.K., WILSON, J.L., BINDER, W. & DAY, R.O. (1996). Effect of μ-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm. Res., 45, 557-563.
22. WALKER, J.S., HOWLETT, C.R. & NAYANAR, V. (1995). Anti-inflammatory effects of kappa-opioids in adjuvant arthritis. Life Sci., 371-378.
23. WALKER, J.S., WILSON, J.L., BINDER, W., SCOTT, C. & CARMODY, J.J. (1997). The anti-inflammatory effects of opioids: their possible relevance to the pathophysiology and treatment of rheumatoid arthritis. Rheum. Arth. ID Res. Alert, 1, 291-299.
24. WILSON, J.L., NAYANAR, V. & WALKER, J.S. (1996). The site of anti-arthritic action of the κ-opioid, U-50,488H, in adjuvant arthritis: importance of local administration. Br. J. Pharmacol., 118, 1754-1760.
25. WOLLEMAN, M., BENYHE, S. & SIMON, J. (1992). The kappa opioid receptor: evidence for the different subtypes. Life Sci., 52, 599-611.
26. WOOD, A. (1885). New method for treating neuralgia by the direct application of opiates to the painful points. Edinburgh Med. Surg. J., 82, 265-281.